Literature DB >> 20496110

Lumbar disk degeneration disease and aggrecan gene polymorphism in northern Iran.

Farhad Mashayekhi1, Gholamreza Shafiee, Masood Kazemi, Parviz Dolati.   

Abstract

Aggrecan is the major component of intervertebral disk matrix proteoglycan with multiple functional domains. To understand the role of aggrecan polymorphism in a part of exon 12 encoding the CS1 domain in lumbar disk degeneration disease, we have analyzed genomic DNA from 71 patients with the disease and 108 healthy individuals in northern Iran. The AGC1 alleles were determined by PCR followed by gel electrophoresis. Twelve AGC1 alleles ranging from 18 to 29 repeats were detected in patients and controls. The most frequent AGC1 allele was 27, followed by 28 in patients and controls. The shorter AGC1 alleles (< or =24 repeats) were more frequent in patients than in controls (37 vs. 16%, P < 0.001). The odds ratio for lumbar disk degeneration was 3.28 (95% confidence interval 1.62-6.65) in carriers of the shorter AGC1 alleles. Our data suggest that carrying shorter AGC1 alleles with less than 24 repeats could predispose a subject to lumbar disk degeneration disease in northern Iran.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20496110     DOI: 10.1007/s10528-010-9350-3

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  12 in total

1.  The postnatal role of Sox9 in cartilage.

Authors:  Stephen P Henry; Shoudan Liang; Kadir C Akdemir; Benoit de Crombrugghe
Journal:  J Bone Miner Res       Date:  2012-12       Impact factor: 6.741

2.  Multiple enhancers associated with ACAN suggest highly redundant transcriptional regulation in cartilage.

Authors:  Gui Hu; Marta Codina; Shannon Fisher
Journal:  Matrix Biol       Date:  2012-07-20       Impact factor: 11.583

Review 3.  Chronic low back pain: a mini-review on pharmacological management and pathophysiological insights from clinical and pre-clinical data.

Authors:  Thomas S W Park; Andy Kuo; Maree T Smith
Journal:  Inflammopharmacology       Date:  2018-05-12       Impact factor: 4.473

4.  A systematic review of the relationship between the distributions of aggrecan gene VNTR polymorphism and degenerative disc disease/osteoarthritis.

Authors:  L Cong; G Tu; D Liang
Journal:  Bone Joint Res       Date:  2018-05-05       Impact factor: 5.853

Review 5.  Genetic background of degenerative disc disease in the lumbar spine.

Authors:  Yoshiharu Kawaguchi
Journal:  Spine Surg Relat Res       Date:  2018-02-28

6.  Evaluation of Anti-inflammatory and Regenerative Efficiency of Naringin and Naringenin in Degenerated Human Nucleus Pulposus Cells: Biological and Molecular Modeling Studies.

Authors:  Vijaya Madhuri Devraj; Satish Kumar Vemuri; Rajkiran Reddy Banala; Shravan Kumar Gunda; Gurava Reddy Av; Subbaiah Gpv
Journal:  Asian Spine J       Date:  2019-10-04

7.  A novel mutation in the ACAN gene in a family with autosomal dominant short stature and intervertebral disc disease.

Authors:  Noboru Uchida; Hironori Shibata; Gen Nishimura; Tomonobu Hasegawa
Journal:  Hum Genome Var       Date:  2020-12-03

8.  Vitamin D receptor gene and aggrecan gene polymorphisms and the risk of intervertebral disc degeneration - a meta-analysis.

Authors:  Ge Xu; Qiang Mei; Daijun Zhou; Jinlin Wu; Luo Han
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

9.  Genetic association studies in lumbar disc degeneration: a systematic review.

Authors:  Pasi J Eskola; Susanna Lemmelä; Per Kjaer; Svetlana Solovieva; Minna Männikkö; Niels Tommerup; Allan Lind-Thomsen; Kirsti Husgafvel-Pursiainen; Kenneth M C Cheung; Danny Chan; Dino Samartzis; Jaro Karppinen
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

10.  The role of matrix metalloproteinase 14 polymorphisms in susceptibility to intervertebral disc degeneration in the Chinese Han population.

Authors:  Jianfeng Zhang; Xiujiang Sun; Jing Liu; Jianqing Liu; Binghua Shen; Lin Nie
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.